Day: February 25, 2026
Martela Corporation, Financial Statements, 25.2.2026, at 8:00 a.m.
The January–December 2025 revenue and operating result increased compared to previous year. Operating result was slightly profitable in October-December 2025, but the operating result for the year remained on loss.
October–December 2025Revenue was EUR 22.8 million (24.7), representing a change of -8.0%
Operating result was EUR 0.1 million (-1.8)
Operating profit per revenue was 0.5% (-7.1%)
The result for the period was EUR -0.5 million (-2.6)
Earnings per share amounted to EUR -0.12 (-0.55)January–December 2025Revenue was EUR 93.7 million (86.7), representing a change of 8.1%
Operating result was EUR -1.1 million (-6.5)
Operating profit per revenue was -1.1% (-7.5%)
The result for the period was EUR -3.5 million (-8.7)
Earnings per share amounted to EUR -0.75...
Vow ASA: Record Q4 revenues and strategy revision concluded
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Oslo, 25 February 2026 – In the fourth quarter, Vow ASA (“Vow” or the “Group”) delivered all time high revenues and improved operational performance. Following the strategy revision, which was concluded in the period, the Group aims to reinforce its position in the Maritime Solutions and Aftersales segments, while a more selective approach will be adopted in the Industrial Solutions Segment.
“The fourth quarter concludes a transitional year for Vow, involving thorough analysis and clear priorities to improve cost control, project execution and working capital. Following a revisit of our strategy, the Group will pursue a more selective approach in order to balance risk and opportunities in Industrial Solutions, while reinforcing our strong position in the Maritime Solutions and Aftersales segments,” says CEO Gunnar Pedersen.
Growth...
TextMagic AS 2025 12 months consolidated unaudited interim report
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
The year 2025 in the TextMagic Group was characterised by several strategic decisions aimed at improving performance and operational efficiency in future periods. During the year, structural changes were implemented, including the sale of one business line and the initiation of the liquidation of a subsidiary, as well as the optimisation of development activities and the cost base.
In 2025, the TextMagic Group generated revenue of €13,549 thousand, representing a 7% decrease compared to 2024 (2024: €14,533 thousand). The decline in revenue was significantly affected by the unfavourable exchange rates of the US dollar and the British pound. If exchange rates had remained at the 2024 level, revenue in 2025 would have totalled €14,015 thousand, representing a decrease of 4%.
The Group recorded an operating loss of €611 thousand (2024: operating...
NORBIT – Advanced negotiations regarding a NOK 115 million contract
Written by Customer Service on . Posted in Public Companies.
Trondheim, 25 February 2026
NORBIT today announces that segment PIR is in advanced negotiations with a European client within defence and security regarding an order for contract manufacturing. The expected value of the order is approximately NOK 115 million, to be delivered in second quarter 2026. The potential contract follows another recently received award of approximately NOK 80 million for deliveries in the same quarter.
“The strong activity in the defence and security market continues, and the delivery window remains short once contracts are awarded. This requires preparedness, scalable capacity and disciplined execution. Our strategic expansions have served us well in positioning NORBIT to deliver under these conditions. Agility and trust define successful partnerships in this market. Contributing to solutions that enhance security...
Basilea receives further USD 6 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam
Written by Customer Service on . Posted in Public Companies.
Ad hoc announcement pursuant to Art. 53 LR
Allschwil, Switzerland, February 25, 2026
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services, awarded USD 6 million to Basilea to continue the development of Basilea’s novel oral antibiotic ceftibuten-ledaborbactam etzadroxil, a beta-lactam/beta-lactamase inhibitor (BL/BLI) combination, for the treatment of complicated urinary tract infections (cUTIs), including pyelonephritis.
David Veitch, Chief Executive Officer of Basilea, said: “We are very pleased...
Vopak announces a multi-year share buyback program of up to EUR 500 million and commences the first tranche of up to EUR 100 million
Written by Customer Service on . Posted in Public Companies.
Vopak announces a multi-year share buyback program of up to EUR 500 million and commences the first tranche of up to EUR 100 million
Rotterdam, the Netherlands, 25th February 2026
Vopak intends to commence a multi-year share buyback program of up to EUR 500 million, expected to be executed by year-end of 2030 in multiple tranches.
This share buyback program is part of the shareholder distributions program of around EUR 1.7 billion through year-end 2030. In addition to the multi-year share buyback program, Vopak has enhanced the progressive dividend policy, through which the company intends to increase its dividend per share by 5% or more annually. For further details please refer to the FY 2025 press release published on 25 February 2026.
The first tranche of the multi-year share buyback program, of up to EUR 100 million, will commence...
Bicara Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock and Pre-Funded Warrants
Written by Customer Service on . Posted in Public Companies.
BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) — Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced the pricing of an underwritten public offering of 7,175,000 shares of its common stock at a public offering price of $16.00 per share and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 2,200,000 shares of common stock at a public offering price of $15.9999 per pre-funded warrant, which represents the per share public offering price for the common stock less the $0.0001 per share exercise price for each pre-funded warrant. The gross proceeds to Bicara from the offering, before deducting underwriting discounts and commissions and offering expenses payable...
Intuitive Machines Announces Date for Fourth Quarter, Full-Year 2025 Financial Results, and Post-Lanteris Space Systems Acquisition Conference Call
Written by Customer Service on . Posted in Public Companies.
HOUSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) — Intuitive Machines, Inc. (Nasdaq: LUNR) (“Intuitive Machines”) (“Company”) announced today that it will release its financial results for the fourth quarter and full-year of 2025 on Thursday, March 19, 2026, before the market opens. Following the news release, the Company will host a conference call the same day at 8:30 am ET to discuss the results as well as growth opportunities following the Lanteris Space Systems acquisition.
To participate in the call, please dial (800) 715-9871 (USA & Canada) or (646) 307-1963 (International) and reference Conference ID 2767132.
A webcast replay will be available on the investors portion of the Intuitive Machines website at https://investors.intuitivemachines.com/.
Please visit the Investor Relations website at https://investors.intuitivemachines.com/...
Digital Realty Expands Innovation Lab Network to Singapore and Japan to Accelerate AI and Hybrid Cloud Implementation
Written by Customer Service on . Posted in Public Companies.
Asia Pacific will provide real-world environments for customers and partners to test and optimize next generation infrastructure
SINGAPORE, Feb. 24, 2026 (GLOBE NEWSWIRE) — Digital Realty (NYSE: DLR), the world’s largest cloud- and carrier-neutral data center platform, today announced the expansion of its Digital Realty Innovation Lab (DRIL) into Singapore and Japan. This marks the first expansion of the company’s global DRIL network into Asia Pacific, following the successful launch of the inaugural DRIL facility in Northern Virginia in September 2025, which received over 120 visits from our enterprise customers.
The new DRIL locations will offer our ecosystem of partners and customers fully supported, real-world testing environments where they can bring their own workloads or use pre-configured infrastructure to validate AI and...
Fairfax Launches C$650 Million Senior Notes Offering
Written by Customer Service on . Posted in Public Companies.
Not for distribution to U.S. news wire services or dissemination in the United States.
The base shelf prospectus is accessible, and the shelf prospectus supplement for this offering will be accessible within two business days, through SEDAR+
TORONTO, Feb. 24, 2026 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces that it intends to offer (i) C$400 million in aggregate principal amount of Senior Notes due 2036 (the “2036 Notes”) to be priced at C$99.968 per C$100 principal amount, and (ii) an additional C$250 million in aggregate principal amount of its 5.10% Senior Notes due 2055 (the “2055 Notes” and, together with the 2036 Notes, the “Senior Notes”) to be priced at C$99.485 per C$100 principal amount, plus accrued interest (the “Offering”). The Senior Notes will be offered through...
